Media headlines about Agilent Technologies (NYSE:A) have trended somewhat positive this week, according to AlphaOne Sentiment. AlphaOne, a division of Accern, scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. AlphaOne ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Agilent Technologies earned a media sentiment score of 0.21 on AlphaOne’s scale. AlphaOne also assigned media stories about the medical research company an impact score of 52 out of 100, meaning that recent press coverage is somewhat likely to have an impact on the stock’s share price in the near future.
These are some of the news articles that may have impacted AlphaOne Sentiment’s analysis:
- Medical Microbiology Testing Technologies Market Research Report: Technologies, Markets and Players (medgadget.com)
- Peeling Back the Layers on Agilent Technologies, Inc. (NYSE:A) and MGM Resorts International (NYSE:MGM) – Geneva Journal (genevajournal.com)
- Global nanosensors market is expected to reach $2466.09 million by 2022 with a CAGR of 73.9%. insights shared in detailed report (whatech.com)
- Agilent Technologies : Announces Cash Dividend of 13.2 Cents per Share (4-traders.com)
- S&P 500, Industrial Giants Dip as Trump Controversies Continue (finance.yahoo.com)
Several research analysts have recently commented on A shares. Janney Montgomery Scott raised their price objective on Agilent Technologies from $55.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, February 13th. Morgan Stanley raised Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $62.00 price objective on the stock in a research note on Wednesday, March 15th. Zacks Investment Research raised Agilent Technologies from a “sell” rating to a “hold” rating in a research note on Friday, February 17th. Deutsche Bank AG reissued a “buy” rating and set a $58.00 target price (up previously from $56.00) on shares of Agilent Technologies in a research note on Sunday, April 2nd. Finally, Jefferies Group LLC reissued a “buy” rating and set a $59.00 target price on shares of Agilent Technologies in a research note on Friday, March 17th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $55.46.
Agilent Technologies (NYSE:A) traded up 0.21% during trading on Friday, reaching $55.97. The company had a trading volume of 294,353 shares. Agilent Technologies has a 52 week low of $41.98 and a 52 week high of $58.38. The firm has a market capitalization of $18.04 billion, a price-to-earnings ratio of 35.90 and a beta of 1.19. The company’s 50-day moving average is $54.57 and its 200 day moving average is $49.85.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, February 14th. The medical research company reported $0.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.04. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.05 billion. Agilent Technologies had a return on equity of 15.49% and a net margin of 10.99%. Agilent Technologies’s revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.46 EPS. Equities analysts anticipate that Agilent Technologies will post $2.16 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd will be issued a dividend of $0.132 per share. The ex-dividend date of this dividend is Thursday, June 29th. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.95%. Agilent Technologies’s payout ratio is 37.59%.
In related news, CEO Michael R. Mcmullen sold 32,511 shares of the company’s stock in a transaction on Monday, May 1st. The shares were sold at an average price of $55.48, for a total transaction of $1,803,710.28. Following the completion of the sale, the chief executive officer now directly owns 260,346 shares of the company’s stock, valued at approximately $14,443,996.08. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Patrick Kaltenbach sold 5,000 shares of the company’s stock in a transaction on Thursday, May 4th. The stock was sold at an average price of $56.50, for a total transaction of $282,500.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 53,614 shares of company stock valued at $2,934,903.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.